KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Gross Margin (2016 - 2025)

Historic Gross Margin for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to 78.26%.

  • Biogen's Gross Margin rose 20300.0% to 78.26% in Q4 2025 from the same period last year, while for Dec 2025 it was 75.69%, marking a year-over-year decrease of 4300.0%. This contributed to the annual value of 75.69% for FY2025, which is 4300.0% down from last year.
  • According to the latest figures from Q4 2025, Biogen's Gross Margin is 78.26%, which was up 20300.0% from 73.39% recorded in Q3 2025.
  • Over the past 5 years, Biogen's Gross Margin peaked at 89.14% during Q1 2022, and registered a low of 73.09% during Q1 2023.
  • Its 5-year average for Gross Margin is 77.84%, with a median of 76.73% in 2024.
  • As far as peak fluctuations go, Biogen's Gross Margin surged by 68900bps in 2022, and later tumbled by -160500bps in 2023.
  • Over the past 5 years, Biogen's Gross Margin (Quarter) stood at 75.85% in 2021, then rose by 2bps to 77.56% in 2022, then decreased by -4bps to 74.09% in 2023, then grew by 3bps to 76.23% in 2024, then rose by 3bps to 78.26% in 2025.
  • Its last three reported values are 78.26% in Q4 2025, 73.39% for Q3 2025, and 77.13% during Q2 2025.